137 related articles for article (PubMed ID: 29665000)
1. Increased killer B cells in chronic HCV infection may lead to autoimmunity and increased viral load.
Eiza N; Zuckerman E; Carlebach M; Rainis T; Goldberg Y; Vadasz Z
Clin Exp Immunol; 2018 Aug; 193(2):183-193. PubMed ID: 29665000
[TBL] [Abstract][Full Text] [Related]
2. Peripheral B-cell CD5 expansion and CD81 overexpression and their association with disease severity and autoimmune markers in chronic hepatitis C virus infection.
Zuckerman E; Slobodin G; Kessel A; Sabo E; Yeshurun D; Halas K; Toubi E
Clin Exp Immunol; 2002 May; 128(2):353-8. PubMed ID: 11985527
[TBL] [Abstract][Full Text] [Related]
3. TLR4 supports the expansion of FasL
Wang K; Tao L; Su J; Zhang Y; Zou B; Wang Y; Zou M; Chen N; Lei L; Li X
Mol Immunol; 2017 Jul; 87():188-199. PubMed ID: 28505514
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C coinfection enhances sensitization of CD4(+) T-cells towards Fas-induced apoptosis in viraemic and HAART-controlled HIV-1-positive patients.
Körner C; Tolksdorf F; Riesner K; Krämer B; Schulte D; Nattermann J; Rockstroh JK; Spengler U
Antivir Ther; 2011; 16(7):1047-55. PubMed ID: 22024520
[TBL] [Abstract][Full Text] [Related]
5. Expansion of innate CD5pos B cells expressing high levels of CD81 in hepatitis C virus infected liver.
Curry MP; Golden-Mason L; Doherty DG; Deignan T; Norris S; Duffy M; Nolan N; Hall W; Hegarty JE; O'Farrelly C
J Hepatol; 2003 May; 38(5):642-50. PubMed ID: 12713876
[TBL] [Abstract][Full Text] [Related]
6. Concentrations of soluble Fas and soluble Fas ligand as indicators of programmed cell death among patients coinfected with Human Immunodeficiency Virus and Hepatitis C Virus.
Lapinski TW; Jaroszewicz J; Wiercinska-Drapalo A
Viral Immunol; 2006; 19(3):570-5. PubMed ID: 16987075
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis of activated CD4+ and CD8+ T cells is enhanced by co-culture with hepatocytes expressing hepatitis C virus (HCV) structural proteins through FasL induction.
Iken K; Huang L; Bekele H; Schmidt EV; Koziel MJ
Virology; 2006 Mar; 346(2):363-72. PubMed ID: 16336987
[TBL] [Abstract][Full Text] [Related]
8. Expansion of peripheral blood CD5+ B cells is associated with mild disease in chronic hepatitis C virus infection.
Curry MP; Golden-Mason L; Nolan N; Parfrey NA; Hegarty JE; O'Farrelly C
J Hepatol; 2000 Jan; 32(1):121-5. PubMed ID: 10673076
[TBL] [Abstract][Full Text] [Related]
9. Fas / FasL system, IL-1beta expression and apoptosis in chronic HBV and HCV liver disease.
Bortolami M; Kotsafti A; Cardin R; Farinati F
J Viral Hepat; 2008 Jul; 15(7):515-22. PubMed ID: 18331250
[TBL] [Abstract][Full Text] [Related]
10. Enhanced apoptosis of peripheral CD5-negative B lymphocytes from chronically hepatitis C virus-infected patients: reversal after antiviral treatment.
Toubi E; Kessel A; Peri R; Shmuel Z; Bamberger E; Sabo E; Zuckerman E
J Virol; 2004 Oct; 78(20):11379-84. PubMed ID: 15452259
[TBL] [Abstract][Full Text] [Related]
11. Peripheral lymphocytes analyses in children with chronic hepatitis C virus infection.
Nafady A; Nafady-Hego H; Abdelwahab NM; Eltellawy RHN; Abu Faddan NH
Eur J Clin Invest; 2018 Oct; 48(10):e13004. PubMed ID: 30022474
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus core protein triggers expansion and activation of CD4(+)CD25(+) regulatory T cells in chronic hepatitis C patients.
Zhai N; Chi X; Li T; Song H; Li H; Jin X; Crispe IN; Su L; Niu J; Tu Z
Cell Mol Immunol; 2015 Nov; 12(6):743-9. PubMed ID: 25531392
[TBL] [Abstract][Full Text] [Related]
13. The 1F7 idiotype is selectively expressed on CD5+ B cells and elevated in chronic hepatitis C virus infection.
Davtyan TK; Hovsepyan MP; Mkhitaryan LM; Hakobyan GS; Brazil A; Barrett L; Hirsch G; Peltekian KM; Grant MD
Immunol Cell Biol; 2009; 87(6):457-63. PubMed ID: 19333248
[TBL] [Abstract][Full Text] [Related]
14. CD8+ T cells of chronic HCV-infected patients express multiple negative immune checkpoints following stimulation with HCV peptides.
Barathan M; Mohamed R; Vadivelu J; Chang LY; Vignesh R; Krishnan J; Sigamani P; Saeidi A; Ram MR; Velu V; Larsson M; Shankar EM
Cell Immunol; 2017 Mar; 313():1-9. PubMed ID: 28104239
[TBL] [Abstract][Full Text] [Related]
15. Antiviral treatment down-regulates peripheral B-cell CD81 expression and CD5 expansion in chronic hepatitis C virus infection.
Zuckerman E; Kessel A; Slobodin G; Sabo E; Yeshurun D; Toubi E
J Virol; 2003 Oct; 77(19):10432-6. PubMed ID: 12970428
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory molecules that regulate expansion and restoration of HCV-specific CD4+ T cells in patients with chronic infection.
Raziorrouh B; Ulsenheimer A; Schraut W; Heeg M; Kurktschiev P; Zachoval R; Jung MC; Thimme R; Neumann-Haefelin C; Horster S; Wächtler M; Spannagl M; Haas J; Diepolder HM; Grüner NH
Gastroenterology; 2011 Oct; 141(4):1422-31, 1431.e1-6. PubMed ID: 21763239
[TBL] [Abstract][Full Text] [Related]
17. Chronic HCV-related autoimmunity: a consequence of viral persistence and lymphotropism.
Kessel A; Toubi E
Curr Med Chem; 2007; 14(5):547-54. PubMed ID: 17346146
[TBL] [Abstract][Full Text] [Related]
18. Increased T and B Regulatory Cell Function Contributes to the Persistence of HCV and Other Viral Infections.
Eiza N; Toubi E; Vadasz Z
Isr Med Assoc J; 2016; 18(3-4):159-61. PubMed ID: 27228634
[No Abstract] [Full Text] [Related]
19. Increased Fas ligand expression of CD4+ T cells by HCV core induces T cell-dependent hepatic inflammation.
Cruise MW; Melief HM; Lukens J; Soguero C; Hahn YS
J Leukoc Biol; 2005 Aug; 78(2):412-25. PubMed ID: 15894587
[TBL] [Abstract][Full Text] [Related]
20. Immunological changes in different patient populations with chronic hepatitis C virus infection.
Szereday L; Meggyes M; Halasz M; Szekeres-Bartho J; Par A; Par G
World J Gastroenterol; 2016 May; 22(20):4848-59. PubMed ID: 27239111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
